-

$undefined

N/A

(N/A)

Rani Therapeutics :RANI

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

61.28M

Cash

30.4M

Avg Qtr Burn

-9.83M

Short % of Float

8.13%

Insider Ownership

27.31%

Institutional Own.

10.86%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
RT-102 (RaniPill® capsule containing teriparatide) Details Osteoporosis	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RT-111 (RaniPill® capsule) Details Psoriasis, Skin disease/disorder	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RT-114 [RaniPill® capsule containing PG-102] Details Obesity	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.